Acetylsalicylic acid Recruiting Phase 2 Trials for Aspirin / Tuberous Sclerosis Complex (TSC) / cutaneous lesions / Epilepsies / Cognitive Decline Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03356769Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex